WebAug 10, 2024 · Inari Medical, Inc. (NARI) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.16 per share a year ago. WebApr 13, 2024 · In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights....
Insider-Verkauf: Inari Medical MarketScreener
WebApr 14, 2024 · April 2024 12.750 Aktien von Inari Medical für $819.432 verkauft. Nach der Einreichung des Formulars 4 bei der SEC hat Hill die Kontrolle über... 15 April 2024-- Mitch C. Hill, Chief Financial Officer, hat am 12. April 2024 12.750 Aktien von Inari Medical für $819.432 verkauft. Nach der Einreichung des Formulars 4 bei der SEC hat Hill die ... WebApr 13, 2024 · In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and … theo todd hockey
Inari Medical - NARI Stock Forecast, Price & News - MarketBeat
WebIRVINE, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2024 financial results on Wednesday, May 3, 2024. WebMar 11, 2024 · Inari’s revenues for the full year were $383.5 million, up $106.5 million or 38% from $277 million for the full year 2024. 36% of this annual growth was driven by our U.S. business, while 2% of... WebInari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. shuff valve